Enovis Corporation

US$27.16As of Sun 8 Nov 2026, 12:00 UTC
NYSE:ENOVHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (6.74%)
Div yield —
ROE (29.95%)
Medical Devices
Beta (5Y) 1.42
PE TTM —
TSR TTM (13.06%)
Mkt cap US$1.567B
ROIC 3.37%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$33
22.25%
(77.21%)
Hold 6|8|9|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.47
0.47
0.50
0.50
25.03%
16.38%
22.82%
18.03%
Revenue$M
89.87
93.88
96.32
93.90
6.24%
12.37%
16.35%
10.24%
Peers (US$1.567B)
Cap (US$)
PE
1.853B
18.36x
1.535B
21.39x
Capital
TTM
5Y
10Y
Leveragex
0.927
0.202
0.177
EBIT/Intx
0.212
0.178
0.141
Own earn%
(67.04)
132.70
122.31
Sh yield%
47.31
10.77
10.58
Owners
Insiders/Inst%
3.01
53.17
Short interest%
0.58
SBC / revenue%
2.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
20–22
$1 testx
—
Incr. ROIC%
1